Company intelligence / Profile preview

AcedrA BioPharmaceuticals

Riyadh, Riyadh, Saudi Arabiaacedrarx.com ↗
Ownership
Private
Employees
~42
Development stage
Commercial
01

Overview

AcedrA BioPharmaceuticals serves as a gateway to the Middle East and North Africa (MENA) market for global biotech/pharma companies by providing regulatory approval support, market access services across more than fourteen countries, and distribution of innovative therapies—especially those addressing unmet needs in rare/orphan disease segments. The company partners with international firms to bring new-to-market and new-in-class products to the region. Recent notable partnership includes exclusive commercialization of Trogarzo (ibalizumab) for multi-drug resistant HIV in MENA.

Therapeutic areas
OncologyMetabolic DisordersRare DiseasesHematologyNeurologyInfectious Diseases
Modalities
Monoclonal antibodyBiologicEnzyme replacement therapyRecombinant proteinSmall moleculeBiosimilarSpecialty medicine
Industry
Consulting
02

Partnerships

TaiMed Biologics – exclusive commercialization/distribution agreement for Trogarzo (ibalizumab) in MENA regionEssential Pharma – distribution agreement covering essential medicines across multiple therapeutic areasAdditional alliances with global biotechs/pharmas seeking entry into MENA markets

Beyond the preview

Go deeper on AcedrA BioPharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AcedrA BioPharmaceuticals.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call